Showing results (221-230 of 682) with videos related to
Sort By:
Pageof 69
Cancer|March 29, 2002
Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemiaSrdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.The Journal of Molecular Diagnostics : JMD|December 17, 2008
Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasiasWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.Blood|February 13, 2019
Myelofibrosis osteoclasts are clonal and functionally impairedIvo Veletic, Taghi Manshouri, Asha S Multani, et al.Cell Death & Disease|May 20, 2022
GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytesTaghi Manshouri, Ivo Veletic, Ping Li, et al.Blood Advances|August 8, 2023
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosisStephen T Oh, Ruben A Mesa, Claire N Harrison, et al.Leukemia Research|May 26, 2004
Telomerase activity is not a prognostic factor in chronic lymphocytic leukemiaSrdan Verstovsek, Francis J Giles, Susan O'Brien, et al.Leukemia Research|March 22, 2003
Empirical examination of the neutrophil criterion (>1500 microl(-1)) currently needed to declare CR in AMLElihu Estey, Francis Giles, Jorge Cortes, et al.Leukemia & Lymphoma|April 12, 2013
Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformationFabio P S Santos, Constantine S Tam, Hagop Kantarjian, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosisVikas Gupta, Jason Gotlib, Jerald P Radich, et al.Leukemia Research|February 18, 2015
Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalitiesChristopher B Benton, Maria Tanaka, Catherine Wilson, et al.Pageof 69